S Korea's Samsung Biologics, Bobcat brave Asia’s second-worst IPO market

S Korea's Samsung Biologics, Bobcat brave Asia’s second-worst IPO market

South Korean 10,000 won note is seen on U.S. 100 dollar notes in this picture illustration taken in Seoul, South Korea, December 15, 2015. REUTERS/Kim Hong-Ji

South Korea’s initial public offerings are the second-worst performers among major Asian markets this year. That hasn’t stopped companies from planning more new listings, which are poised to raise the most since 2010.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter